Tyro3 facilitates cytoplasmic delivery of extracellular vesicle contents and antigen presentation via major histocompatibility complex class I in dendritic cells
PLOS One · 04.08.2026 · 21 (8) · e0355054
DOI: 10.1371/journal.pone.0355054 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 04.08.2026. Verfasst von Takashi Koyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Tumor Immunobiology, Miyagi Cancer Center Research Institute, Natori, Japan. Hauptthemen laut MEDLINE: Dendritic Cells, Receptor Protein-Tyrosine Kinases, Antigen Presentation, Histocompatibility Antigens Class I. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Core Research for Evolutional Science and Technology, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Extracellular vesicles (EVs) are membrane-bound particles that mediate intercellular communication and are being explored as carriers for antigen delivery in cancer immunotherapy. However, the molecular mechanisms underlying the uptake of antigen-carrying EVs by dendritic cells (DCs) remain unclear. EV uptake is influenced by the recognition of EV surface components by receptors on recipient cells. Phospholipids, including phosphatidylserine (PS), are common structural components of EV membrane. We therefore focused on the TAM receptor tyrosine kinases Tyro3, Axl, and Mertk, which are expressed in antigen-presenting cells and engage PS-exposing membranes through the bridging ligands Growth arrest-specific 6 (Gas6) and Protein S (Pros1). Using the DC2.4 dendritic cell line as a model system, we investigated the involvement of TAM receptors in the uptake of small EVs (sEVs) and subsequent antigen presentation. We found that Tyro3 binding to sEVs was enhanced by Gas6 and Pros1, and that Tyro3 also associated with phosphatidylserine (PS) and phosphatidylglycerol (PG) through these bridging ligands. Among TAM receptors, only Tyro3 markedly enhanced sEV internalization in DC2.4 cells. Deletion analysis indicated that the immunoglobulin C2-type domain (IG2c domain) of Tyro3 is required for efficient sEV association and uptake. Moreover, Tyro3-mediated internalization enabled cross-presentation of sEV-delivered antigens and activation of CD8 + T cells. This function required a 46-amino acid intracellular region of Tyro3, which we designated the Tyro3 antigen presentation-related domain (TAPD); deletion of TAPD impaired cross-presentation of sEV-delivered antigens. Finally, we observed an increase in the frequency of Tyro3 ⁺ DCs in the spleens of tumor-bearing mice. These findings suggest that Tyro3 mediates sEV uptake and antigen cross-presentation in DCs and may represent a candidate molecular target for EV-based cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Tumor Immunobiology, Miyagi Cancer Center Research Institute, Natori, Japan.
- Division of Tumor Immunobiology, Tohoku University Graduate School of Medicine, Sendai, Japan.
- Department of Immunology and Microbiology, Shinshu University School of Medicine, Matsumoto, Japan.
- Department of Biochemistry and Molecular Biology, Faculty of Agriculture and Life Science, Hirosaki University, Hirosaki, Japan.
- Department of Microbiology and Immunology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
- Laboratory of Membrane Trafficking Mechanisms, Department of Integrative Life Sciences, Graduate School of Life Sciences, Tohoku University, Sendai, Japan.
ORCID-Profile: Takashi Koyama
Förderung
- Japan Society for the Promotion of Science
- Core Research for Evolutional Science and Technology
- Japan Agency for Medical Research and Development
Zitieren
APA
Koyama, T., Kojima, K., Maeda, K., Matsui, T., Kosai, H., Ishida, N., Morita, E., Fukuda, M., & Tanaka, N. (2026). Tyro3 facilitates cytoplasmic delivery of extracellular vesicle contents and antigen presentation via major histocompatibility complex class I in dendritic cells. PLOS One, 21(8), e0355054. https://doi.org/10.1371/journal.pone.0355054
Vancouver
Koyama T, Kojima K, Maeda K, Matsui T, Kosai H, Ishida N, et al. Tyro3 facilitates cytoplasmic delivery of extracellular vesicle contents and antigen presentation via major histocompatibility complex class I in dendritic cells. PLOS One. 2026;21(8):e0355054. doi:10.1371/journal.pone.0355054
BibTeX
@article{Koyama2026,
author = {Koyama, Takashi and Kojima, Katsuhiko and Maeda, Koki and Matsui, Takahide and Kosai, Hitomi and Ishida, Noriko and Morita, Eiji and Fukuda, Mitsunori and Tanaka, Nobuyuki},
title = {Tyro3 facilitates cytoplasmic delivery of extracellular vesicle contents and antigen presentation via major histocompatibility complex class I in dendritic cells},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0355054},
doi = {10.1371/journal.pone.0355054}
}
EUVIMED